Glaia

What Glaia does

Glaia is a UK-based agricultural biotechnology company that develops nanotechnology-enabled biostimulant products designed to improve the Light Use Efficiency (LUE) of crops. Its core technology is a platform of bioavailable carbon dots — nanoscale carbon-based materials — that, when applied to plants, are claimed to enhance photosynthetic activity and improve yields. The company's first commercial product, Fragaria Plus, is a biostimulant formulation for commercial strawberry growers and was made commercially available in 2024. Glaia is also developing a pipeline of carbon dot biostimulants targeting cereals, potatoes, sugar beet, and leafy vegetables, indicating a multi-crop product strategy beyond the initial strawberry focus.

The company was founded in 2018-2019, originating from research at the University of Bristol and with support from Rothamsted Research. Glaia operates with a small team of 1-10 employees and has raised approximately £1.21 million to date, comprising a £210,000 Innovate UK grant and a £1 million investment from the Green Angel Syndicate. Its go-to-market model relies on agronomy distribution partners in the UK to reach commercial growers, and the company has stated intentions to expand into EU and North American markets, with selection for the SVG Ventures THRIVE US expansion programme in 2026 as a concrete step toward the latter.

Glaia's technology is protected by patents on its carbon dot synthesis and formulation, and the company has built an evidence base from over 30 independent field trials demonstrating crop response. Revenue generation is at a nascent stage following the 2024 UK commercial launch, and the company is in a capital-raising and product-expansion phase.

Name

Glaia

Legal name

Glaia Limited

Website

https://glaia.co.uk

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Glaia is a UK-based agricultural biotech company that develops carbon dot-based biostimulant products to enhance crop Light Use Efficiency. It sells Fragaria Plus to commercial strawberry growers in the UK and is developing formulations for cereals, potatoes, sugar beet, and leafy vegetables.

Ownership category

akta.pro rank

Product category

Agricultural Biostimulants

NAICS

Pesticide and Other Agricultural Chemical Manufacturing (32532)

SIC

Agricultural Chemicals (2870)

akta.pro primary industry

Biostimulants & Plant Health Biologicals (Microbial/Non-microbial) (AFABAEAK)

akta.pro secondary industry

Bio-based Fertilizers, Soil Amendments & Biostimulants (Digestate-derived, biochar-based inputs) (EUAAAIAH)

Keywords

• Crop biostimulants
• Light use efficiency
• Agricultural nanotechnology
• Photosynthesis enhancement
• Sustainable agriculture inputs

Headquarters

HQ city

Bristol

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Product Sales - Fragaria Plus: Sale of Fragaria Plus, a Light Use Efficiency technology product for strawberry crops. The product is sold through distribution channels in the UK and is applied as part of existing spray programmes at 250ml per hectare at 7-10 day intervals during active crop growth.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Core offering

Glaia develops and sells bioavailable carbon dot-based biostimulant products that improve Light Use Efficiency (LUE) in crops, enabling plants to convert more sunlight into biomass and yield. Its commercial product Fragaria Plus is a spray-applied LUE biostimulant for strawberry growers, with crop-specific products for cereals, potatoes, sugar beet, and leafy vegetables in development.

Product overview

Glaia offers a Light Use Efficiency (LUE) technology platform based on unique, bioavailable carbon dot technology that enhances photosynthesis efficiency in crops. The commercially available product is Fragaria Plus, designed for strawberry growers. The company is developing additional crop-specific products including Cereal, Potato, Sugar Beet, and Lettuce & Leafy Vegetable formulations, all built around the same core carbon dot technology that helps plants convert more sunlight into biomass without requiring additional inputs or changes to farming practices.

Differentiator

Problem solved

Functional benefit

Brands

• Fragaria Plus: Light Use Efficiency technology product for strawberry crops, designed to improve photosynthesis and increase yield by up to 8% average yield increase across 13 independent trials.

Products and services

• Fragaria Plus Light Use Efficiency (LUE) biostimulant for commercial strawberry growers that improves photosynthesis efficiency to convert more sunlight into crop yield, applied as part of existing spray programmes at 250ml per hectare at 7-10 day intervals; delivers up to 8% average yield increase across 13 independent trials.

Quantifiable outcome

• 9% average yield increase across 30+ independent trials
• +5 more outcomes

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• SVG Ventures | THRIVEcoreStrategic or Co-development Partner · 4 June 2026Selected for the Innovate UK and SVG Ventures | THRIVE US expansion programme designed to help startups scale into the United States market. The nine-month programme provides virtual support, mentorship, and two in-market visits to California, including participation in the 2026 Salinas Biological Summit and the THRIVE Global Impact Summit.
• University of BristolcoreStrategic or Co-development PartnerGlaia technology was developed from advanced research into plant physiology and photosynthesis at the University of Bristol. The company was born out of this research and shaped by its founders Dr. David Benito and Dr. Imke Sittel.
• Rothamsted ResearchcoreStrategic or Co-development PartnerGlaia is supported by Rothamsted Research, one of the world's oldest agricultural research institutions, providing scientific credibility and research partnership.
• StartLife Agri-Food Tech AcceleratorminorStrategic or Co-development PartnerGlaia is supported by StartLife, an agri-food tech accelerator that supports innovative startups in the agricultural sector.
• Prof. Tracy LawsoncoreStrategic or Co-development PartnerR&D Advisor and Professor at the University of Essex, member of the RIPE project (Bill & Melinda Gates Foundation). Specialist in photosynthesis and plant productivity providing scientific advisory.
• Keith NormanminorStrategic or Co-development PartnerAgronomy Advisor - Former Technical Director at Velcourt with 35+ years in UK and European agronomy. Supports trial interpretation and grower engagement.
• Dr. David FlanderscoreStrategic or Co-development PartnerChair of Advisory Board, CEO of Agrimetics and co-founder of GrainSense. Experienced in commercialisation and strategic partnerships in life sciences and agtech.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Plant Response Biotech: Spanish plant biotech company developing biostimulant and crop protection products using proprietary microbial and natural active ingredients. Direct comparable as a Europe-based biologicals company commercialising novel biostimulant formulations to specialty and row crop growers.
• Sound Agriculture: US-based agtech company developing on-demand crop nutrition and biostimulant products (notably SOURCE) that improve nutrient use efficiency. Closely comparable to Glaia as a venture-backed biological input company commercialising novel-mode-of-action biostimulants to row and specialty crop growers.
• Symborg: Spanish biostimulants and biocontrol company (now part of Corteva) specialising in microbial and botanical agricultural inputs. Comparable as a European-headquartered biostimulant business that scaled from startup to acquisition by a global ag-input major.
• Pivot Bio: US agtech company developing microbial nitrogen-fixing biostimulant products for corn and other cereals. Closely comparable as a venture-backed biologicals company with a novel active ingredient approach to improving crop input efficiency in row crops.
• BioConsortia: US-based microbial solutions company developing biostimulant and biocontrol products from identified microbial consortia. Directly comparable as an early-to-growth stage biological input developer targeting row crops with proprietary active ingredients.
• Concentric Ag Corporation: Canada-based agtech company developing proprietary endophyte-based biostimulant and biocontrol products for broad-acre crops. Comparable as a venture-stage biologicals company commercialising novel microbial-derived crop inputs to growers.
• Lallemand Plant Care: Canadian/French division of Lallemand focused on biological plant care products including biostimulants, biocontrol and biofertilisers. Comparable as an established biologicals company commercialising multi-crop biostimulant portfolios to commercial growers globally.
• NewLeaf Symbiotics: US agtech company developing pink pigmented facultative methylotrophs (PPFMs) as biostimulant and biocontrol products for row crops. Direct comparable as a venture-backed biologicals company commercialising novel microbe-based biostimulants to broad-acre and specialty crops.

Emerging players

• Indigo Ag: US agtech company that developed microbe-based seed treatments and biostimulants and has since expanded into grain marketing and sustainability programmes. Comparable as a venture-backed biologicals developer targeting row crop growers with novel input technologies.

Broad incumbents

• Syngenta Group: Global crop protection and seed company with a growing biologicals and biostimulant portfolio through Syngenta Biologicals and acquisitions. Comparable as the largest scale incumbent competing in biostimulants and crop input adjacencies that Glaia ultimately targets, and notably the former employer of board advisor Martin Brown.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/GlaiaLtd
• LinkedInlinkedin.com/company/glaia
• Instagraminstagram.com/glaia_ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Glaia